Sputnik V nasal vaccine, Russia’s health ministry has register its first nasal version of its vaccine to fight against Covid-19. This is the world’s first nasal vaccine against the COVID-19 virus. The second phase of clinical trials of the Sputnik V nasal spray form was authorize by the Russian health ministry back in October 2021.
According to the reports in January, the Russian news agency TASS note that the nasal version of the vaccine to fight against the novel coronavirus infection will be up for civil circulation and available for Russia in 3-4 months’ time, quoting Alexander Gintsburg, the director of the Gamaleya Centre, a research institute that manufactures Sputnik V.
Gintsburg told TASS that the Laboratory tests of Sputnik V show protection against Omicron in its ordinary injection form and would also be effective in the nasal form as well.
In India, the Sputnik V coronavirus vaccine was first administer in Hyderabad in May 2021 and the first consignment of the vaccine had land in India on 1st May 2021 and went on to receive a regulatory clearance on 13th May, 2021, from the Central Drugs Laboratory.
Sputnik V tweeted :
“Russian Health Ministry registers the nasal version of Sputnik V, the world’s first nasal vaccine against COVID-19,”.
The Sputnik-V vaccine was develop by researchers at Gamaleya National Research Centre for Epidemiology and Microbiology in Moscow.
